EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity

Philip Samaan, Chapin S Korosec, Patrick Budylowski, Serena L L Chau, Adrian Pasculescu, Freda Qi, Melanie Delgado-Brand, Tulunay R Tursun, Geneviève Mailhot, Roya Monica Dayam, Corey R Arnold, Marc-André Langlois iD und 19 weitere

Journal of Virology · 18.03.2025 · 99 (3)

DOI: 10.1128/jvi.01685-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 18.03.2025. Verfasst von Philip Samaan und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, T-Lymphocytes, BNT162 Vaccine, 2019-nCoV Vaccine mRNA-1273. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR), Ontario Genomics (OG), COVID-19 Immunity Task Force.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The contributions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells to vaccine efficacy and durability are unclear. We investigated relationships between mRNA vaccine-induced spike-specific interferon- gamma (IFN-γ) and interleukin-2 (IL-2) T-cell responses and neutralizing antibody development in long-term care home staff doubly vaccinated with BNT162b2 or mRNA-1273. The impacts of pre-existing cross-reactive T-cell immunity on cellular and humoral responses to vaccination were additionally assessed. Mathematical modeling of the kinetics of spike-specific IFN-γ and IL-2 T-cell responses over 6 months post-second dose was bifurcated into recipients who exhibited gradual increases with doubling times of 155 and 167 days or decreases with half-lives of 165 and 132 days, respectively. Differences in kinetics did not correlate with clinical phenotypes. Serological anti-spike IgG, anti-receptor binding domain (RBD) IgG, anti-spike IgA, and anti-RBD IgA antibody levels otherwise decayed in all participants with half-lives of 63, 57, 79, and 46 days, respectively, alongside waning neutralizing capacity ( t 1/2 = 408 days). Spike-specific T-cell responses induced at 2–6 weeks positively correlated with live viral neutralization at 6 months post-second dose, especially in hybrid immune individuals. Participants with pre-existing cross-reactive T-cell immunity to SARS-CoV-2 exhibited greater spike-specific T-cell responses, reduced anti-RBD IgA antibody levels, and a trending increase in neutralization at 2–6 weeks post-second dose. Non-spike-specific T-cells predominantly targeted SARS-CoV-2 non-structural protein at 6 months post-second dose in cross-reactive participants. mRNA vaccination was lastly shown to induce off-target T-cell responses against unrelated antigens. In summary, vaccine-induced spike-specific T-cell immunity appeared to influence serological neutralizing capacity, with only a modest effect induced by pre-existing cross-reactivity. IMPORTANCE Our findings provide valuable insights into the potential contributions of mRNA vaccine-induced spike-specific T-cell responses to the durability of neutralizing antibody levels in both uninfected and hybrid immune recipients. Our study additionally sheds light on the precise impacts of pre-existing cross-reactive T-cell immunity to severe acute respiratory syndrome coronavirus 2 on the magnitude and kinetics of cellular and humoral responses to vaccination. Accordingly, our data will help optimize the development of next-generation T cell-based coronavirus vaccines and vaccine regimens to maximize efficacy and durability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusT-LymphocytesBNT162 Vaccine2019-nCoV Vaccine mRNA-1273Antibodies, ViralInterferon-gammaInterleukin-2HumansLong-Term CareHealth PersonnelCross ReactionsMaleFemaleYoung AdultAdultMiddle AgedAgedNeutralization TestsAntibodies, Neutralizing

Stichwörter der Autor:innen

SARS-CoV-2T-cell immunitycross-reactivityhumoral immunityhybrid immunitymRNA vaccines

Substanzen

spike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusBNT162 Vaccine2019-nCoV Vaccine mRNA-1273Antibodies, ViralInterferon-gammaInterleukin-2Antibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Modelling Infection and Immunity Lab, Mathematics and Statistics, York University, Toronto, Ontario, Canada.
  • Center for Disease Modelling, Mathematics and Statistics, York University, Toronto, Ontario, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.

ORCID-Profile: Marc-André Langlois, Mario Ostrowski

Förderung

  • Canadian Government | Canadian Institutes of Health Research (CIHR)
  • Ontario Genomics (OG)
  • COVID-19 Immunity Task Force
  • Canadian Government | National Research Council Canada (NRC)
  • New Frontiers Research Foundation Grant
  • Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Juan and Stefania Speck Fund
  • Canada Foundation for Innovation (CFI)

Zitieren

APA

Samaan, P., Korosec, C. S., Budylowski, P., Chau, S. L. L., Pasculescu, A., Qi, F., Delgado-Brand, M., Tursun, T. R., Mailhot, G., Dayam, R. M., Arnold, C. R., Langlois, M. A., Mendoza, J., Morningstar, T., Law, R., Mihelic, E., Sheikh-Mohamed, S., Cao, E. Y., Paul, N., …, & Ostrowski, M. (2025). mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity. Journal of Virology, 99(3). https://doi.org/10.1128/jvi.01685-24

Vancouver

Samaan P, Korosec CS, Budylowski P, Chau SLL, Pasculescu A, Qi F, et al. mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity. Journal of Virology. 2025;99(3). doi:10.1128/jvi.01685-24

BibTeX
@article{Samaan2025,
  author = {Samaan, Philip and Korosec, Chapin S and Budylowski, Patrick and Chau, Serena L L and Pasculescu, Adrian and Qi, Freda and Delgado-Brand, Melanie and Tursun, Tulunay R and Mailhot, Geneviève and Dayam, Roya Monica and Arnold, Corey R and Langlois, Marc-André and Mendoza, Justin and Morningstar, Thomas and Law, Ryan and Mihelic, Erik and Sheikh-Mohamed, Salma and Cao, Eric Yixiao and Paul, Nimitha and Patel, Anjali and de Launay, Keelia Quinn and Boyd, Jamie M and Takaoka, Alyson and Colwill, Karen and Matveev, Vitaliy and Yue, Feng Yun and McGeer, Allison and Straus, Sharon and Gingras, Anne-Claude and Heffernen, Jane M and Ostrowski, Mario},
  title = {mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {3},
  doi = {10.1128/jvi.01685-24}
}
Kostenlos starten →